The Ohio State University Dermatology Biorepository (NCT03146676) | Clinical Trial Compass
RecruitingNot Applicable
The Ohio State University Dermatology Biorepository
United States175 participantsStarted 2017-04-19
Plain-language summary
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol
* Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
* Willingness to participate in a research study.
Exclusion Criteria:
* Inability to provide informed consent
What they're measuring
1
Source of clinical specimens for the future study of neoplastic and inflammatory skin disorders